Novel Quinolinylaminoisoquinoline Bioisosteres of Sorafenib as Selective RAFI Kinase Inhibitors: Design, Synthesis, and Antiproliferative Activity against Melanoma Cell Line
- Title
- Novel Quinolinylaminoisoquinoline Bioisosteres of Sorafenib as Selective RAFI Kinase Inhibitors: Design, Synthesis, and Antiproliferative Activity against Melanoma Cell Line
- Author
- 최정훈
- Keywords
- 1,3,4-TRIARYLPYRAZOLE SCAFFOLD; THERAPEUTIC TARGET; DERIVATIVES; DIARYLAMIDES; DIARYLUREAS
- Issue Date
- 2013-07
- Publisher
- Pharmaceutical SOC Japan
- Citation
- Chemical and Pharmaceutical Bulletin , 2013, 61(7), P.747-756
- Abstract
- Design and synthesis of a new series of quinolinylaminoisoquinoline derivatives as conformationally restricted bioisosteres of Sorafenib are described. Their in vitro antiproliferative activity against A375P melanoma cell line was tested. Compounds 1b, id, 1g, and 1j showed the highest potency against A375P cell line with IC50 values in sub-micromolar scale. In addition, compound id exerted high selectivity towards RAF1 serine/threonine kinase with 96.47% inhibition at 101 mu m, and IC50 of 0.961 mu m. This compound can possess antiproliferative activity against melanoma cells through inhibition of RAF1 kinase.
- URI
- https://www.jstage.jst.go.jp/article/cpb/61/7/61_c13-00283/_article
- ISSN
- 0009-2363
- DOI
- 10.1248/cpb.c13-00283
- Appears in Collections:
- CENTER FOR CREATIVE CONVERGENCE EDUCATION[S](창의융합교육원) > ETC
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML